• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

• Catalysts and Inorganic Chemicals Inorganic Compounds Salt
• Catalysts and Inorganic Chemicals Inorganic Compounds

Copper(II) Sulfate (7758-98-7) in Biomedical Research: Applications and Innovations

Copper(II) Sulfate (CAS 7758-98-7), a versatile inorganic compound, has garnered significant attention in biomedical research due to its unique chemical properties and therapeutic potential. Researchers have explored its role in antimicrobial agents, anticancer therapies, and wound healing, leveraging its ability to interact with biological systems. Recent studies highlight its efficacy against multidrug-resistant pathogens, making it a promising candidate for next-generation antibiotics. Additionally, its redox-active nature facilitates the generation of reactive oxygen species (ROS), which can be harnessed for targeted cancer cell apoptosis. The compound's compatibility with nanotechnology further expands its applications, such as in copper-based nanoparticles for drug delivery.

Copper(II) Sulfate (7758-98-7): Pharmacokinetics and Safety in Drug Development

The pharmacokinetics of Copper(II) Sulfate (7758-98-7) is a critical area of study, particularly for its integration into pharmaceutical formulations. Its absorption, distribution, metabolism, and excretion (ADME) profiles are influenced by factors such as solubility and ligand interactions. Recent clinical trials emphasize the importance of dose optimization to mitigate potential toxicity while maximizing therapeutic effects. Regulatory agencies like the FDA and EMA have established guidelines for its use in nutraceuticals and topical treatments, ensuring patient safety. Advances in chelation therapy have also addressed concerns about copper accumulation, paving the way for safer applications in chronic diseases like Wilson's disease.

Copper(II) Sulfate (7758-98-7) in Nanomedicine: Breakthroughs and Future Directions

In the realm of nanomedicine, Copper(II) Sulfate (7758-98-7) has emerged as a cornerstone for designing smart therapeutics. Its incorporation into hybrid nanomaterials enhances drug stability and bioavailability, addressing challenges in precision medicine. For instance, copper-doped hydrogels exhibit controlled release properties for chronic wound management, while copper-oxide nanoparticles show promise in photothermal therapy for tumors. Collaborative research between chemists and biologists is unlocking novel delivery mechanisms, such as enzyme-responsive carriers, tailored to specific disease microenvironments. These innovations underscore the compound's potential to revolutionize personalized healthcare.

Copper(II) Sulfate (7758-98-7) and Immune Modulation: A New Frontier in Therapeutics

The immunomodulatory effects of Copper(II) Sulfate (7758-98-7) are reshaping strategies for autoimmune diseases and vaccine adjuvants. Studies reveal its capacity to regulate cytokine production and macrophage polarization, offering a dual approach to inflammation control and infection resistance. In vaccine development, copper-based formulations enhance antigen presentation, improving immune response durability. This aligns with the growing demand for broad-spectrum immunotherapies, particularly in post-pandemic research. Furthermore, its role in metalloenzyme function provides insights into metabolic disorders, bridging gaps in nutrient-based therapeutics.

Sustainable Synthesis of Copper(II) Sulfate (7758-98-7): Eco-Friendly Approaches for Pharma

Sustainability in the production of Copper(II) Sulfate (7758-98-7) is gaining traction, with green chemistry methods reducing environmental impact. Techniques like solvent-free synthesis and biogenic extraction from copper-rich biomass are minimizing waste and energy consumption. These advancements align with the pharmaceutical industry's shift toward carbon-neutral manufacturing, meeting both regulatory and consumer demands for eco-conscious products. Lifecycle assessments highlight the compound's potential in circular economy models, where recycled copper sources are repurposed for high-purity medical-grade applications.

• 10380-29-7(TETRAAMMINECOPPER (II) SULFATE HYDRATE)
• 17599-81-4(Sulfuric acid,copper(1+) salt (1:2))
• 12013-15-9(tricopper tetrahydroxide sulphate)
• 12158-97-3(Copper oxysulfate)
• 10257-54-2(Copper sulfate monohydrate)
• 7758-99-8(Copper(II) sulfate pentahydrate)
• 1332-14-5(Sulfuricacid, copper(2+) salt, basic)
• 1344-73-6(Copper Sulfate, Basic)
• 13587-26-3(Ammonium copper(II) sulfate hexahydrate)
• 10124-44-4(Sulfuric acid, coppersalt (8CI,9CI))